Tristan Gill

Tristan Gill is an experienced professional in the bioscience industry with a strong emphasis on business development and consulting. Tristan is currently the CEO and Founder at Pythia Biosciences, a company that specializes in software and services for multi-omics data analysis. Prior to Pythia Biosciences, they founded and served as CEO of Chimeric Bioscience Consulting, which aimed to accelerate and optimize the therapeutic discovery and development process for pharmaceutical customers.

Tristan also has experience as a Knowledgebase Application Consultant at Biorelate Ltd., where they worked with pharmaceutical companies to apply a large causal knowledge graph for various purposes such as target discovery and interpretation of multi-omics data.

In addition, Tristan has held various roles in business development and sales at companies such as immunEyez, BioTuring, Clarivate Analytics, Thomson Reuters, Appistry, BGI Americas, and Ingenuity Systems. These roles have provided him with a deep understanding of the bioscience industry and the ability to connect pharmaceutical customers with the best solutions for their needs.

Overall, Tristan Gill has a strong track record in business development and consulting within the bioscience industry, and their expertise contributes to the successful growth and optimization of companies in the field.

Tristan Gill attended Stony Brook University from 1993 to 1997. However, the provided information does not mention the degree obtained or the field of study pursued during this period.